The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF-mutant colorectal cancer cell lines.


ÇELTİKÇİ B., Carson R., Johnston P. G., Van Schaeybroeck S.

JOURNAL OF CLINICAL ONCOLOGY, Chicago, 30 May - 03 June 2014, vol.32